Weight-loss-drug price war is on, as Wegovy prices cut for monthly subscribers

March 5, 2025

https://images.mktw.net/im-66737327

Published: March 5, 2025 at 9:00 a.m. ET

Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes.

The company’s

NVO move comes a week after Eli Lilly & Co. LLY cut prices for its rival weight-loss drug Zepbound.

This post was originally published on Market Watch

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…

Weight-loss-drug price war is on, as Wegovy prices cut for monthly subscribers

Share:

Latest News

Adobe’s earnings beat shows investors that AI is finally paying off, and the stock rises

Klarna goes public as more people say buy-now-pay-later is the only way they can afford to buy things

Social Security checks could increase 2.8% in 2026 as more seniors face poverty

ECB signals it may be done cutting rates as Fed gets ready to resume easing

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Financial News

Daily News on Investing, Personal Finance, Markets, and more!